219 related articles for article (PubMed ID: 28982149)
21. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia.
Capitani N; Lucherini OM; Sozzi E; Ferro M; Giommoni N; Finetti F; De Falco G; Cencini E; Raspadori D; Pelicci PG; Lauria F; Forconi F; Baldari CT
Blood; 2010 May; 115(18):3726-36. PubMed ID: 20061561
[TBL] [Abstract][Full Text] [Related]
22. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A
Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725
[TBL] [Abstract][Full Text] [Related]
23. Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.
Zurli V; Wimmer G; Cattaneo F; Candi V; Cencini E; Gozzetti A; Raspadori D; Campoccia G; Sanseviero F; Bocchia M; Baldari CT; Kabanova A
Blood; 2017 Nov; 130(18):2006-2017. PubMed ID: 28931525
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
[TBL] [Abstract][Full Text] [Related]
25. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
[TBL] [Abstract][Full Text] [Related]
26. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract][Full Text] [Related]
27. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer SW; Piñón JD; Brachtl G; Haginger L; Wang W; Jöhrer K; Tinhofer I; Hartmann TN; Greil R
Cancer Res; 2010 Sep; 70(18):7336-44. PubMed ID: 20823161
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
[TBL] [Abstract][Full Text] [Related]
29. Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response.
Romanets-Korbut O; Kovalevska LM; Seya T; Sidorenko SP; Horvat B
Cell Mol Immunol; 2016 Nov; 13(6):828-838. PubMed ID: 26073466
[TBL] [Abstract][Full Text] [Related]
30. Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. II. receptor-mediated Akt/PKB and ERK1/2 activation and transcription factors expression profile.
Shlapatska LM; Kovalevska LM; Gordiienko IM; Sidorenko SP
Exp Oncol; 2014 Sep; 36(3):162-9. PubMed ID: 25265348
[TBL] [Abstract][Full Text] [Related]
31. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
[TBL] [Abstract][Full Text] [Related]
32. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
33. CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.
Liu FT; Giustiniani J; Farren T; Jia L; Bensussan A; Gribben JG; Agrawal SG
Blood; 2010 Apr; 115(15):3079-88. PubMed ID: 20164468
[TBL] [Abstract][Full Text] [Related]
34. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.
Seda V; Vojackova E; Ondrisova L; Kostalova L; Sharma S; Loja T; Mladonicka Pavlasova G; Zicha D; Kudlickova Peskova M; Krivanek J; Liskova K; Kren L; Benes V; Musilova Litzmanova K; Borsky M; Oppelt J; Verner J; Pospisilova S; Brychtova Y; Panovska A; Tan Z; Zhang S; Doubek M; Amruz Cerna K; Mayer J; Mraz M
Blood; 2021 Sep; 138(9):758-772. PubMed ID: 33786575
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
36. Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment.
Shen Y; Crassini K; Sandhu S; Fatima N; Christopherson RI; Mulligan SP; Best OG
Leuk Lymphoma; 2019 Jul; 60(7):1632-1643. PubMed ID: 30648436
[TBL] [Abstract][Full Text] [Related]
37. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J
J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331
[TBL] [Abstract][Full Text] [Related]
39. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
[TBL] [Abstract][Full Text] [Related]
40. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
